Your browser doesn't support javascript.
loading
The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanoma.
O'Day, Roderick F; Conway, R Max; Lim, Li-Anne; Giblin, Michael; Cherepanoff, Svetlana; Joshua, Anthony; McKay, Daniel; McKenzie, John D; Fog, Lotte S; Holly, Peta; Shackleton, Mark; Kee, Damien; Philips, Claire; McKelvie, Penny; Bhikoo, Riyaz; Hadden, Peter; Negretti, Guy S; Sagoo, Mandeep S; Damato, Bertil E; Sia, David; McGrath, Lindsay; Glasson, William; Isaacs, Timothy; Gillies, Mark; Barthelmes, Daniel.
Afiliação
  • O'Day RF; Ocular Oncology Research Unit, Centre for Eye Research Australia, Melbourne (Victoria), Australia; Department of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia. Electronic address: roderick.o'day@eyeandear.org.au.
  • Conway RM; Ocular Oncology Unit, Sydney Eye Hospital and The Kinghorn Cancer Centre, Sydney (New South Wales), Australia; Save Sight Institute, University of Sydney, Sydney (New South Wales), Australia.
  • Lim LA; Ocular Oncology Unit, Sydney Eye Hospital and The Kinghorn Cancer Centre, Sydney (New South Wales), Australia; Save Sight Institute, University of Sydney, Sydney (New South Wales), Australia.
  • Giblin M; Ocular Oncology Unit, Sydney Eye Hospital and The Kinghorn Cancer Centre, Sydney (New South Wales), Australia.
  • Cherepanoff S; SydPath, Department of Anatomical Pathology, St Vincent's Hospital, Darlinghurst (New South Wales), Australia.
  • Joshua A; Kinghorn Cancer Centre, St Vincent's Hospital Sydney, Darlinghurst (New South Wales), Australia; Garvan Institute of Medical Research, Darlinghurst (New South Wales), Australia.
  • McKay D; Ocular Oncology Research Unit, Centre for Eye Research Australia, Melbourne (Victoria), Australia; Department of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia.
  • McKenzie JD; Ocular Oncology Research Unit, Centre for Eye Research Australia, Melbourne (Victoria), Australia; Department of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia.
  • Fog LS; Ocular Oncology Research Unit, Centre for Eye Research Australia, Melbourne (Victoria), Australia; Alfred Health, Melbourne (Victoria), Australia.
  • Holly P; Department of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia.
  • Shackleton M; Alfred Health, Melbourne (Victoria), Australia; Central Clinical School, Monash University, Melbourne (Victoria), Australia.
  • Kee D; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne (Victoria), Australia; Department of Medical Oncology, Austin Health, Heidelberg (Victoria), Australia.
  • Philips C; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne (Victoria), Australia; Department of Medical Oncology, Austin Health, Heidelberg (Victoria), Australia.
  • McKelvie P; Department of Ophthalmology, University of Auckland, Auckland, New Zealand.
  • Bhikoo R; Department of Ophthalmology, University of Auckland, Auckland, New Zealand.
  • Hadden P; Department of Ophthalmology, University of Auckland, Auckland, New Zealand.
  • Negretti GS; Department of Ocular Oncology and NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, United Kingdom.
  • Sagoo MS; Department of Ocular Oncology and NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, United Kingdom.
  • Damato BE; Department of Ocular Oncology and NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, United Kingdom.
  • Sia D; Departments of Ophthalmology at the Royal Adelaide Hospital and Flinders Medical Centre, Adelaide (South Australia), Australia; The University of Adelaide, Faculty of Health and Medical Sciences, Adelaide (South Australia), Australia.
  • McGrath L; Queensland Ocular Oncology Service, Brisbane (Queensland), Australia.
  • Glasson W; Queensland Ocular Oncology Service, Brisbane (Queensland), Australia.
  • Isaacs T; University of Western Australia, Perth (Western Australia), Australia.
  • Gillies M; Save Sight Institute, University of Sydney, Sydney (New South Wales), Australia.
  • Barthelmes D; Save Sight Institute, University of Sydney, Sydney (New South Wales), Australia; Department of Ophthalmology, University Hospital and University of Zurich, Zurich, Switzerland.
Can J Ophthalmol ; 2024 May 26.
Article em En | MEDLINE | ID: mdl-38810958
ABSTRACT

OBJECTIVE:

To describe the development of a web-based data collection tool to track the management and outcomes of uveal melanoma patients.

DESIGN:

Description of a clinical registry.

PARTICIPANTS:

Patients with uveal melanoma.

METHODS:

A panel of expert ocular oncologists, with input from other relevant specialties and individuals with expertise in registry development, collaborated to formulate a minimum data set to be collected to track patient centred, real-world outcomes in uveal melanoma. This data set was used to create the Fight Tumour Blindness! (FTB!) registry within Save Sight Registries.

RESULTS:

The data set to be collected includes patient demographics and medical history, baseline visit, follow-up visit including tumour treatment, metastatic staging and surveillance, pathology, and patient-reported questionnaires. The inbuilt mechanisms to ensure efficient and complete data collection are described.

CONCLUSIONS:

The FTB! registry can be used to monitor outcomes for patients with uveal melanoma. It allows benchmarking of outcomes and comparisons between different clinics and countries.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Can J Ophthalmol Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Can J Ophthalmol Ano de publicação: 2024 Tipo de documento: Article